Sort
64,565 grants matching “drug discovery”
The Partnership for Native American Cancer Prevention (1 of 2)
$1,629,320Laura F. Huenneke · Northern Arizona University · U54 · FY2009 · CA
Identifying the genetic causes of depression in a deeply phenotyped population from South Korea
$1,628,438Jonathan Flint · University Of California Los Angeles · U01 · FY2022 · MH
Discovery of genes required for expression or activity of fusion oncogenes
$1,627,567Natasha Caplen · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Tissue Based Small Animal Model for HIV Drug Discovery
$1,627,399University Of California, San Francisco · N01 · FY2010 · AI
Novel Chemical and Immunological Approaches to Influenza Therapy
$1,627,220Michael B Oldstone · Scripps Research Institute, The · U01 · FY2009 · AI
Chemistry Core
$1,627,045Zoran Rankovic · St. Jude Children'S Research Hospital · U54 · FY2019 · CA
Dysregulation of Protein Synthesis in Fragile X Syndrome and Other Developmental Disorders
$1,626,666Carolyn B. Smith · National Institute Of Mental Health · ZIA · FY2016 · MH
Interventional approaches for restoring vision
$1,626,636Anand Swaroop · National Eye Institute · ZIA · FY2012 · EY
High-throughput genetic & small-molecule screening for therapeutic modifiers
$1,625,965Kevin P. Campbell · University Of Iowa · RC2 · FY2009 · NS
Functional MRI Method Development
$1,625,551Peter Bandettini · National Institute Of Mental Health · ZIA · FY2013 · MH
Novel Adjuvants/Delivery Systems for Biodefense Vaccines
$1,624,853Novartis Vaccines And Diagnostics, Inc. · U01 · FY2005 · AI
Pathogenesis and treatment of autoinflammatory diseases i.e.NOMID,DIRA,CANDLE, SAVI and others
$1,624,774Raphaela Goldbach-Mansky · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2014 · AR
Subcellular protein localization in B. subtilis
$1,624,730Kumaran Ramamurthi · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Development of Orexin-1 Receptor Antagonists for Drug Addiction
$1,624,668Theodore M Kamenecka · Scripps Research Institute, The · P01 · FY2013 · DA
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
$1,623,635Li-Huei Tsai · Massachusetts Institute Of Technology · U01 · FY2020 · AG
SBIR Phase II: An omics-based computational drug design and discovery platform for next generation microbiome therapeutics
$1,623,498Mohammad Soheilypour · Nexilico, Inc. · · FY2023 · TIP
Acquisition of a High Frequency Pulsed Electron Spin Resonance Spectrometer
$1,623,490Sunil K Saxena · University Of Pittsburgh At Pittsburgh · S10 · FY2011 · RR
Functional Selectivity: A Novel approach for CNS Drug Discovery
$1,623,361Bryan L Roth · Univ Of North Carolina Chapel Hill · U19 · FY2011 · MH
Deign and Utility of Novel Protienaceous Biomaterials
$1,623,342William Joel Schneider · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
KnowEng, a Scalable Knowledge Engine for Large-Scale Genomic Data-OVERALL
$1,623,265Jiawei Han · University Of Illinois At Urbana-Champaign · U54 · FY2014 · GM
Development of drugs that target the M2 proton channel from the influenza A Virus
$1,623,145William F Degrado · University Of Pennsylvania · U01 · FY2010 · AI
Development of a Chimeric Syphilis Vaccine Candidate to Combat Local, Disseminated and Congenital Syphilis Infection
$1,622,474Caroline E Cameron · University Of Victoria · U01 · FY2024 · AI
STANFORD CENTER FOR CLINICAL AND TRANSLATIONAL EDUCATION AND RESEARCH (SCCTER)UL
$1,622,006Harry Bernard Greenberg · Stanford University · UL1 · FY2009 · RR
Novel Protease Inhibitors as SARS Therapeutics
$1,621,464University Of Illinois At Chicago · P01 · FY2005 · AI
Resources to interpret genetic signals and multi-tissue mechanisms for type 2 diabetes and related traits
$1,620,238Karen L Mohlke · Univ Of North Carolina Chapel Hill · RC2 · FY2025 · DK